Cash flow Hester Biosciences Limited

Equities

HESTERBIO

INE782E01017

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:30:48 10/04/2026 pm IST			5-day change	1st Jan Change
1,450.00 ^INR	+2.25%		+1.55%	-8.92%

11/03	Hester Biosciences Gets Board Nod to Divest 43.8% Stake in Subsidiary; Shares Up 3%	MT
11/03	Hester Biosciences approves divestment of 43.81% equity in Texas Lifesciences	RE

4e51f658c0f6a3a1c4dc56019e7.ukcn71j77r9TR5TpjYypmR6VRZ4G6vkVAYbbmnTqPUs.jAtXqx3JmtYqDNjdzL_d3DOjENRLg6tiONGj9jmQcB7fI3G5C5Wn-gcSpA

Published financial data: HESTER BIOSCIENCES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	214.33Cr	235.01Cr	266.09Cr	304.55Cr	311.1Cr
Other Revenues, Total	3.36Cr	12Cr	12Cr	6.65Cr	1.37Cr
Total Revenues	217.7Cr	246.63Cr	278.2Cr	311.19Cr	312.47Cr
Cost of Goods Sold, Total	53Cr	66Cr	82Cr	100Cr	93Cr
Gross Profit	164.99Cr	180.95Cr	195.72Cr	211.47Cr	219.64Cr
Selling General & Admin Expenses, Total	46Cr	52Cr	68Cr	75Cr	73Cr
Provision for Bad Debts	69L	1.99Cr	-	-	-
Depreciation & Amortization - (IS)	13Cr	17Cr	21Cr	17Cr	17Cr
Other Operating Expenses	46Cr	56Cr	65Cr	76Cr	84Cr
Other Operating Expenses, Total	105.86Cr	125.91Cr	153.7Cr	168.34Cr	174.02Cr
Operating Income	59Cr	55Cr	42Cr	43Cr	46Cr
Interest Expense, Total	-6.06Cr	-2.58Cr	-5.15Cr	-9.12Cr	-8.34Cr
Interest And Investment Income	1.29Cr	1.9Cr	2.17Cr	1.91Cr	2.04Cr
Net Interest Expenses	-4.77Cr	-67.3L	-2.98Cr	-7.21Cr	-6.3Cr
Income (Loss) On Equity Invest.	-	42.3L	4.41Cr	4.61Cr	4.1Cr
Currency Exchange Gains (Loss)	-40.3L	-45.9L	-2.99Cr	-9.47Cr	-3.36Cr
Other Non Operating Income (Expenses)	-54.2L	-95.7L	-33.1L	-31L	-48.6L
EBT, Excl. Unusual Items	53Cr	53Cr	40Cr	31Cr	40Cr
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	2L	12.5L	2L	3L	-
Other Unusual Items	-3.32Cr	-	-	1.18Cr	-
EBT, Incl. Unusual Items	50Cr	54Cr	40Cr	32Cr	40Cr
Income Tax Expense	15Cr	14Cr	12Cr	11Cr	11Cr
Earnings From Continuing Operations	35Cr	39Cr	28Cr	21Cr	29Cr
Net Income to Company	35Cr	39Cr	28Cr	21Cr	29Cr
Minority Interest	-26.8L	-16.4L	-1.41Cr	-2.28Cr	-1.34Cr
Net Income - (IS)	34Cr	39Cr	27Cr	19Cr	27Cr
Net Income to Common Incl Extra Items	34Cr	39Cr	27Cr	19Cr	27Cr
Net Income to Common Excl. Extra Items	34Cr	39Cr	27Cr	19Cr	27Cr
Per Share Items
Net EPS - Basic	40.47	46.22	31.3	22.2	32.31
Basic EPS - Continuing Operations	40.47	46.22	31.3	22.2	32.31
Basic Weighted Average Shares Outstanding	85.07L	85.07L	85.07L	85.07L	85.07L
Net EPS - Diluted	40.47	46.22	31.3	22.2	32.31
Diluted EPS - Continuing Operations	40.47	46.22	31.3	22.2	32.31
Diluted Weighted Average Shares Outstanding	85.07L	85.07L	85.07L	85.07L	85.07L
Normalized Basic EPS	38.92	39.02	27.83	19.91	27.5
Normalized Diluted EPS	38.92	39.02	27.83	19.91	27.5
Dividend Per Share	10	10	8	6	7
Payout Ratio	16.31	21.64	31.95	36.03	18.8
Supplemental Items
EBITDA	72Cr	71Cr	62Cr	60Cr	62Cr
EBITA	59Cr	55Cr	42Cr	43Cr	46Cr
EBIT	59Cr	55Cr	42Cr	43Cr	46Cr
EBITDAR	73Cr	73Cr	64Cr	62Cr	65Cr
Total Revenues (As Reported)	219.02Cr	248.75Cr	281.24Cr	315.18Cr	315.03Cr
Effective Tax Rate - (Ratio)	30.75	26.2	30.18	33.76	27.15
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	17Cr	15Cr	11Cr	11Cr	13Cr
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-1.54Cr	-76.6L	84.1L	6L	-1.48Cr
Normalized Net Income	33Cr	33Cr	24Cr	17Cr	23Cr
Interest Capitalized	-	-	10Cr	9.45Cr	6.8Cr
Interest on Long-Term Debt	-	-	11Cr	9.75Cr	7.12Cr
Non-Cash Pension Expense	17.4L	-2L	-3L	-4L	20T
Supplemental Operating Expense Items
Advertising Expense	5.64Cr	4.96Cr	9.97Cr	8.81Cr	7.77Cr
Selling and Marketing Expenses	5.64Cr	4.96Cr	9.97Cr	8.81Cr	7.77Cr
Research And Development Expense From Footnotes	1.02Cr	1.24Cr	3.39Cr	4.66Cr	5.95Cr
Net Rental Expense, Total	1.31Cr	1.31Cr	1.54Cr	2.33Cr	2.65Cr
Imputed Operating Lease Interest Expense	54.1L	15.93L	75.37L	1.34Cr	1.34Cr
Imputed Operating Lease Depreciation	77.3L	1.15Cr	79.13L	99.55L	1.32Cr
Maintenance & Repair Expenses, Total	2.49Cr	2.96Cr	5Cr	3.85Cr	4.51Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	21Cr	25Cr	13Cr	13Cr	5.96Cr
Short Term Investments	-	45.3L	1.66Cr	2.56Cr	1.25Cr
Total Cash And Short Term Investments	21Cr	25Cr	15Cr	15Cr	7.22Cr
Accounts Receivable, Total	49Cr	55Cr	80Cr	79Cr	73Cr
Other Receivables	23.9L	1.76Cr	3.6Cr	5.78Cr	6.91Cr
Notes Receivable	18Cr	6.08Cr	5.99Cr	5.86Cr	5.76Cr
Total Receivables	67Cr	63Cr	89Cr	90Cr	86Cr
Inventory	62Cr	75Cr	85Cr	76Cr	70Cr
Prepaid Expenses	98.7L	2.39Cr	1.28Cr	1.27Cr	1.68Cr
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	9.58Cr	29Cr	37Cr	32Cr	30Cr
Total Current Assets	161.51Cr	194.76Cr	227.59Cr	214.62Cr	195.17Cr
Gross Property Plant And Equipment	335.87Cr	427.11Cr	530.38Cr	548.27Cr	565.46Cr
Accumulated Depreciation	-95Cr	-110.07Cr	-125.34Cr	-140.69Cr	-156.1Cr
Net Property Plant And Equipment	241.33Cr	317.04Cr	405.04Cr	407.58Cr	409.35Cr
Long-term Investments	2.81Cr	24Cr	27Cr	31Cr	36Cr
Goodwill	-	-	-	-	-
Other Intangibles, Total	42.1L	2.04Cr	2.94Cr	3.93Cr	6.66Cr
Loans Receivable Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	4.98Cr	24Cr	7.67Cr	5.55Cr	6.54Cr
Total Assets	411.05Cr	562.16Cr	669.97Cr	662.35Cr	653.38Cr
Liabilities
Accounts Payable, Total	28Cr	18Cr	30Cr	26Cr	29Cr
Accrued Expenses, Total	3.06Cr	1.63Cr	2.96Cr	2.48Cr	2.68Cr
Short-term Borrowings	3.28Cr	35Cr	59Cr	31Cr	30Cr
Current Portion of Long-Term Debt	18Cr	23Cr	24Cr	26Cr	55Cr
Current Portion of Leases	10.7L	44.4L	50L	4L	-
Current Income Taxes Payable	3.08Cr	93.8L	3.4Cr	2.46Cr	4.02Cr
Unearned Revenue Current, Total	3.53Cr	-	1.27Cr	50.4L	50.4L
Other Current Liabilities	1.94Cr	18Cr	27Cr	17Cr	3.8Cr
Total Current Liabilities	61Cr	97Cr	148.7Cr	105.78Cr	125.18Cr
Long-Term Debt	83Cr	164.37Cr	184.81Cr	181.77Cr	133.37Cr
Long-Term Leases	5.52Cr	5.44Cr	5.67Cr	5.34Cr	5.48Cr
Unearned Revenue Non Current	18Cr	20Cr	33Cr	54Cr	54Cr
Pension & Other Post Retirement Benefits	-	19.5L	21.6L	26.4L	37.4L
Deferred Tax Liability Non Current	7.28Cr	6.51Cr	7.35Cr	7.41Cr	5.93Cr
Other Non Current Liabilities	-	1.08Cr	1.72Cr	4.52Cr	2.38Cr
Total Liabilities	175.09Cr	294.77Cr	381.42Cr	359.47Cr	326.73Cr
Common Stock, Total	8.51Cr	8.51Cr	8.51Cr	8.51Cr	8.51Cr
Additional Paid In Capital	18Cr	18Cr	18Cr	18Cr	18Cr
Retained Earnings	193.47Cr	224.04Cr	242.27Cr	254.32Cr	276.31Cr
Comprehensive Income and Other	8.82Cr	9.93Cr	11Cr	11Cr	12Cr
Total Common Equity	228.31Cr	259.98Cr	279.73Cr	291.79Cr	314.26Cr
Minority Interest	7.65Cr	7.41Cr	8.82Cr	11Cr	12Cr
Total Equity	235.96Cr	267.39Cr	288.55Cr	302.88Cr	326.66Cr
Total Liabilities And Equity	411.05Cr	562.16Cr	669.97Cr	662.35Cr	653.38Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	85.07L	85.07L	85.07L	85.07L	85.07L
ECS Total Common Shares Outstanding	85.07L	85.07L	85.07L	85.07L	85.07L
Book Value / Share	268.38	305.62	328.83	343.01	369.41
Tangible Book Value	227.89Cr	257.94Cr	276.79Cr	287.86Cr	307.6Cr
Tangible Book Value Per Share	267.89	303.22	325.38	338.39	361.59
Total Debt	109.7Cr	228.17Cr	274.15Cr	244.38Cr	223.61Cr
Net Debt	88Cr	202.96Cr	259.34Cr	229.07Cr	216.39Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	-29.4L	-36.7L	-46.7L	3L	82.7L
Debt Equivalent Oper. Leases	11Cr	10Cr	12Cr	19Cr	21Cr
Minority Interest, Total (Incl. Fin. Div)	7.65Cr	7.41Cr	8.82Cr	11Cr	12Cr
Equity Method Investments, Total	-	21Cr	25Cr	30Cr	34Cr
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	9.43Cr	11Cr	13Cr	12Cr	12Cr
Inventories - Work In Process, Total	29Cr	15Cr	15Cr	13Cr	10Cr
Inventories - Finished Goods, Total	23Cr	48Cr	53Cr	47Cr	43Cr
Inventories - Others	1.36Cr	1.47Cr	4.23Cr	3.76Cr	6.06Cr
Land - (BS)	7.28Cr	10Cr	14Cr	14Cr	14Cr
Buildings, Total	84Cr	139.64Cr	159.39Cr	155.42Cr	155.18Cr
Machinery, Total	126.7Cr	192.07Cr	205.88Cr	205.31Cr	214.05Cr
Full Time Employees	428	584	693	642	562
Accumulated Allowance for Doubtful Accounts (Supple)	28.7L	63L	70L	90L	5.37Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	34Cr	39Cr	27Cr	19Cr	27Cr
Depreciation & Amortization - CF	13Cr	16Cr	21Cr	17Cr	17Cr
Amortization of Goodwill and Intangible Assets - (CF)	4L	4L	4L	5L	6L
Depreciation & Amortization, Total	13Cr	17Cr	21Cr	17Cr	17Cr
Amortization of Deferred Charges, Total - (CF)	5L	6L	12.2L	11L	18.5L
(Gain) Loss From Sale Of Asset	2.32Cr	-7L	-2L	-3L	48.6L
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-	-42.3L	-4.41Cr	-4.61Cr	-4.1Cr
Provision and Write-off of Bad Debts	97.7L	2.46Cr	52.8L	71.2L	4.47Cr
Other Operating Activities, Total	7.79Cr	-10Cr	1.01Cr	12Cr	9.42Cr
Change In Accounts Receivable	8.25Cr	-8.78Cr	-25Cr	39.5L	1.62Cr
Change In Inventories	1.75Cr	-13Cr	-9.43Cr	9.23Cr	5.2Cr
Change In Accounts Payable	8.06Cr	-10Cr	12Cr	-3.54Cr	3.65Cr
Change in Other Net Operating Assets	-19Cr	-6.68Cr	1.59Cr	-2.46Cr	-52.5L
Cash from Operations	58Cr	8.81Cr	24Cr	48Cr	65Cr
Capital Expenditure	-41Cr	-96Cr	-78Cr	-24Cr	-21Cr
Sale of Property, Plant, and Equipment	4L	17.9L	2L	6L	27.4L
Cash Acquisitions	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	1.06Cr	-21Cr	22.8L	-20.6L	48.8L
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	1.27Cr	26.4L	51L	1.89Cr	82.6L
Cash from Investing	-38Cr	-116.59Cr	-77Cr	-23Cr	-19Cr
Short Term Debt Issued, Total	-	32Cr	24Cr	-	-
Long-Term Debt Issued, Total	6.37Cr	103.35Cr	32Cr	20Cr	-
Total Debt Issued	6.37Cr	134.91Cr	56Cr	20Cr	-
Short Term Debt Repaid, Total	-29Cr	-	-	-28Cr	-1.77Cr
Long-Term Debt Repaid, Total	-	-18Cr	-17Cr	-23Cr	-32Cr
Total Debt Repaid	-29Cr	-18Cr	-17Cr	-51Cr	-33Cr
Issuance of Common Stock	-	-	-	-	-
Common Dividends Paid	-5.62Cr	-8.51Cr	-8.51Cr	-6.8Cr	-5.17Cr
Common & Preferred Stock Dividends Paid	-5.62Cr	-8.51Cr	-8.51Cr	-6.8Cr	-5.17Cr
Other Financing Activities, Total	10Cr	3.25Cr	11Cr	11Cr	-13Cr
Cash from Financing	-18Cr	111.61Cr	42Cr	-26Cr	-52Cr
Foreign Exchange Rate Adjustments	-3.72Cr	-34.9L	5L	15.7L	-51.1L
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	-2.26Cr	3.48Cr	-12Cr	-40.8L	-6.72Cr
Supplemental Items
Cash Interest Paid	4.02Cr	2.54Cr	13Cr	15Cr	13Cr
Cash Income Tax Paid (Refund)	14Cr	17Cr	8.11Cr	12Cr	11Cr
Levered Free Cash Flow	1.71Cr	-76Cr	-51Cr	11Cr	36Cr
Unlevered Free Cash Flow	5.5Cr	-75Cr	-48Cr	17Cr	41Cr
Change In Net Working Capital	4.03Cr	30Cr	17Cr	3.04Cr	-17Cr
Net Debt Issued / Repaid	-23Cr	116.87Cr	39Cr	-30Cr	-33Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	9.26	7.07	4.26	4.05	4.33
Return on Total Capital	10.9	8.18	4.96	4.86	5.13
Return On Equity %	15.68	15.69	10.09	7.16	9.16
Return on Common Equity	16.04	16.1	9.87	6.61	9.07
Margin Analysis
Gross Profit Margin %	75.79	73.37	70.35	67.95	70.29
SG&A Margin	21.08	20.92	24.28	24.19	23.31
EBITDA Margin %	33.09	28.91	22.44	19.28	19.85
EBITA Margin %	27.18	22.34	15.12	13.87	14.62
EBIT Margin %	27.16	22.32	15.11	13.86	14.6
Income From Continuing Operations Margin %	15.94	16.01	10.08	6.8	9.22
Net Income Margin %	15.82	15.94	9.57	6.07	8.8
Net Avail. For Common Margin %	15.82	15.94	9.57	6.07	8.8
Normalized Net Income Margin	15.21	13.46	8.51	5.44	7.49
Levered Free Cash Flow Margin	0.78	-31.02	-18.24	3.53	11.56
Unlevered Free Cash Flow Margin	2.52	-30.36	-17.09	5.36	13.23
Asset Turnover
Asset Turnover	0.55	0.51	0.45	0.47	0.47
Fixed Assets Turnover	0.95	0.88	0.77	0.77	0.76
Receivables Turnover (Average Receivables)	3.98	4.5	3.94	3.85	4.1
Inventory Turnover (Average Inventory)	0.84	0.95	1.03	1.24	1.27
Short Term Liquidity
Current Ratio	2.63	2.01	1.53	2.03	1.56
Quick Ratio	1.15	0.85	0.66	0.94	0.7
Operating Cash Flow to Current Liabilities	0.95	0.09	0.16	0.46	0.52
Days Sales Outstanding (Average Receivables)	91.66	81.15	92.53	95.11	89.06
Days Outstanding Inventory (Average Inventory)	436.92	382.37	354.45	294.32	286.93
Average Days Payable Outstanding	172.28	106.73	95.3	114.07	115.11
Cash Conversion Cycle (Average Days)	356.3	356.79	351.67	275.35	260.88
Long Term Solvency
Total Debt/Equity	46.49	85.33	95.01	80.69	68.45
Total Debt / Total Capital	31.74	46.04	48.72	44.66	40.64
LT Debt/Equity	37.31	63.51	66.01	61.78	42.5
Long-Term Debt / Total Capital	25.47	34.27	33.85	34.19	25.23
Total Liabilities / Total Assets	42.6	52.43	56.93	54.27	50.01
EBIT / Interest Expense	9.75	21.37	8.16	4.73	5.47
EBITDA / Interest Expense	11.94	27.78	12.16	6.6	7.46
(EBITDA - Capex) / Interest Expense	5.22	-9.37	-2.94	3.93	4.99
Total Debt / EBITDA	1.52	3.19	4.38	4.06	3.59
Net Debt / EBITDA	1.22	2.84	4.14	3.81	3.48
Total Debt / (EBITDA - Capex)	3.47	-9.45	-18.08	6.83	5.37
Net Debt / (EBITDA - Capex)	2.79	-8.41	-17.11	6.4	5.2
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	15.94	13.29	12.79	11.86	0.41
Gross Profit, 1 Yr. Growth %	4.74	9.68	9.45	8.04	3.86
EBITDA, 1 Yr. Growth %	19.98	-1.03	-12.44	-3.88	3.4
EBITA, 1 Yr. Growth %	26.15	-6.89	-23.62	2.63	5.81
EBIT, 1 Yr. Growth %	26.17	-6.9	-23.65	2.62	5.78
Earnings From Cont. Operations, 1 Yr. Growth %	11.92	13.79	-29	-24.5	36.19
Net Income, 1 Yr. Growth %	18.03	14.2	-32.28	-29.06	45.52
Normalized Net Income, 1 Yr. Growth %	39.92	0.25	-28.67	-28.46	38.09
Diluted EPS Before Extra, 1 Yr. Growth %	18.03	14.2	-32.28	-29.06	45.52
Accounts Receivable, 1 Yr. Growth %	-15.78	12.33	44.05	-1.24	-6.95
Inventory, 1 Yr. Growth %	-2.73	21.15	12.51	-10.88	-6.89
Net Property, Plant and Equip., 1 Yr. Growth %	11.57	31.51	27.76	0.63	0.43
Total Assets, 1 Yr. Growth %	6.32	36.76	19.18	-1.14	-1.35
Tangible Book Value, 1 Yr. Growth %	13.56	13.4	7.31	4	6.86
Common Equity, 1 Yr. Growth %	13.55	13.87	7.59	4.31	7.7
Cash From Operations, 1 Yr. Growth %	57.87	-84.83	170.84	103.99	33.89
Capital Expenditures, 1 Yr. Growth %	-44.57	134.92	-18.75	-68.63	-15.6
Levered Free Cash Flow, 1 Yr. Growth %	-103.58	-5.6T	-33.65	-121.66	-1.63T
Unlevered Free Cash Flow, 1 Yr. Growth %	-112.59	-1.55T	-36.52	-135.11	1.14T
Dividend Per Share, 1 Yr. Growth %	51.52	0	-20	-25	16.67
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	8.72	14.61	13.05	12.33	5.98
Gross Profit, 2 Yr. CAGR %	2.94	7.18	8.92	8.74	5.93
EBITDA, 2 Yr. CAGR %	-1.52	8.97	-6.91	-8.26	-0.31
EBITA, 2 Yr. CAGR %	-2.8	8.38	-15.67	-11.47	4.21
EBIT, 2 Yr. CAGR %	-2.8	8.38	-15.69	-11.48	4.19
Earnings From Cont. Operations, 2 Yr. CAGR %	-7.66	12.85	-10.11	-26.78	1.4
Net Income, 2 Yr. CAGR %	-8.99	16.1	-12.06	-30.69	1.6
Normalized Net Income, 2 Yr. CAGR %	-4.69	18.44	-15.44	-28.56	-0.6
Diluted EPS Before Extra, 2 Yr. CAGR %	-8.99	16.1	-12.06	-30.69	1.6
Accounts Receivable, 2 Yr. CAGR %	22.37	-2.74	27.21	19.28	-4.14
Inventory, 2 Yr. CAGR %	10.69	8.56	16.75	0.13	-8.91
Net Property, Plant and Equip., 2 Yr. CAGR %	26.26	21.07	29.62	13.38	0.53
Total Assets, 2 Yr. CAGR %	17.16	20.59	27.67	8.55	-1.25
Tangible Book Value, 2 Yr. CAGR %	13.47	13.37	10.31	5.64	5.42
Common Equity, 2 Yr. CAGR %	13.43	13.71	10.69	5.94	5.99
Cash From Operations, 2 Yr. CAGR %	11.48	-51.06	-36.25	135.05	65.35
Capital Expenditures, 2 Yr. CAGR %	34.11	14.11	38.15	-49.51	-48.54
Levered Free Cash Flow, 2 Yr. CAGR %	-40.22	26.71	503.94	-62.09	-15.63
Unlevered Free Cash Flow, 2 Yr. CAGR %	-17.59	30.98	202.93	-52.79	-6.74
Dividend Per Share, 2 Yr. CAGR %	-4.65	23.09	-10.56	-22.54	-6.46
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	16.6	10.22	14	12.65	8.2
Gross Profit, 3 Yr. CAGR %	13.11	5.14	7.51	8.63	7.09
EBITDA, 3 Yr. CAGR %	13.36	-1.36	1.31	-5.91	-4.53
EBITA, 3 Yr. CAGR %	14.01	-4.18	-3.56	-9.97	-6.05
EBIT, 3 Yr. CAGR %	14.02	-4.19	-3.56	-9.98	-6.07
Earnings From Cont. Operations, 3 Yr. CAGR %	14.58	-1	-3.3	-15.19	-9.96
Net Income, 3 Yr. CAGR %	10.35	-1.84	-3	-18.14	-11.25
Normalized Net Income, 3 Yr. CAGR %	9.68	-3.07	0.02	-20.02	-11.01
Diluted EPS Before Extra, 3 Yr. CAGR %	10.35	-1.84	-3	-18.14	-11.25
Accounts Receivable, 3 Yr. CAGR %	15.08	18.93	10.87	16.91	9.8
Inventory, 3 Yr. CAGR %	16.1	14.07	9.86	6.7	-2.26
Net Property, Plant and Equip., 3 Yr. CAGR %	19.51	27.94	23.26	19.13	8.89
Total Assets, 3 Yr. CAGR %	18.98	23.36	20.11	17.24	5.14
Tangible Book Value, 3 Yr. CAGR %	17.64	13.38	11.31	8.17	6.04
Common Equity, 3 Yr. CAGR %	17.53	13.58	11.63	8.52	6.52
Cash From Operations, 3 Yr. CAGR %	15.15	-42.66	-13.75	-6.05	94.91
Capital Expenditures, 3 Yr. CAGR %	21.05	61.66	1.9	-15.71	-40.08
Levered Free Cash Flow, 3 Yr. CAGR %	5.07	152.04	2.13	99.16	-22.12
Unlevered Free Cash Flow, 3 Yr. CAGR %	82.98	109.94	2.88	47.7	-17.96
Dividend Per Share, 3 Yr. CAGR %	0	-3.13	6.62	-15.66	-11.21
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	16.63	14.88	15.17	11.06	10.72
Gross Profit, 5 Yr. CAGR %	15.77	14.25	11.41	6.31	6.87
EBITDA, 5 Yr. CAGR %	16.19	11.55	4.77	-4.18	0.66
EBITA, 5 Yr. CAGR %	15.88	9.88	1.05	-7.17	-0.52
EBIT, 5 Yr. CAGR %	15.91	9.88	1.05	-7.17	-0.53
Earnings From Cont. Operations, 5 Yr. CAGR %	12.59	11.62	3.98	-12.26	-1.45
Net Income, 5 Yr. CAGR %	12.39	10.8	0.77	-14.59	-1.18
Normalized Net Income, 5 Yr. CAGR %	16.12	10.5	-1.16	-14.21	-0.23
Diluted EPS Before Extra, 5 Yr. CAGR %	12.39	10.8	0.77	-14.59	-1.18
Accounts Receivable, 5 Yr. CAGR %	13.4	15.81	19.79	19.07	4.6
Inventory, 5 Yr. CAGR %	13.1	17.67	16.36	8.28	1.93
Net Property, Plant and Equip., 5 Yr. CAGR %	19.17	20.81	23.43	21.91	13.61
Total Assets, 5 Yr. CAGR %	17.21	21.44	22.38	17.21	11.07
Tangible Book Value, 5 Yr. CAGR %	17.66	16.3	14.61	10.22	8.92
Common Equity, 5 Yr. CAGR %	17.55	16.35	14.74	10.46	9.34
Cash From Operations, 5 Yr. CAGR %	25.23	-24.03	-9.1	0.6	11.9
Capital Expenditures, 5 Yr. CAGR %	24	25.91	27.62	1.49	-22.47
Levered Free Cash Flow, 5 Yr. CAGR %	-25.47	185.04	103.01	18.13	-5.38
Unlevered Free Cash Flow, 5 Yr. CAGR %	0.81	99.18	121.22	15.58	-1.08
Dividend Per Share, 5 Yr. CAGR %	19.52	13.54	-4.36	-11.42	1.18